Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential

Authors: Stutzman M.J., Kim C.S., Tester D.J., Hamrick S.K., Dotzler S.M., Giudicessi J.R., Miotto M.C., Jeevan B. GC, Frank J,  Marks A.R., Ackerman M.J. 

Stem Cell Reports Volume 17, Issue 9, 2022